Alkermes Plc (ALKS)
47.41
-1.49
(-3.05%)
USD |
NASDAQ |
Aug 28, 16:00
47.46
+0.06
(+0.12%)
After-Hours: 20:00
Alkermes Free Cash Flow : 221.65M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 221.65M |
| March 31, 2026 | 221.80M |
| December 31, 2025 | 480.33M |
| September 30, 2025 | 490.87M |
| June 30, 2025 | 479.84M |
| March 31, 2025 | 481.58M |
| December 31, 2024 | 405.64M |
| September 30, 2024 | 315.22M |
| June 30, 2024 | 327.15M |
| March 31, 2024 | 394.23M |
| December 31, 2023 | 353.30M |
| September 30, 2023 | 254.12M |
| June 30, 2023 | 159.01M |
| March 31, 2023 | -59.26M |
| December 31, 2022 | -17.21M |
| September 30, 2022 | 14.13M |
| June 30, 2022 | 101.94M |
| March 31, 2022 | 139.71M |
| December 31, 2021 | 72.70M |
| September 30, 2021 | 112.24M |
| June 30, 2021 | 88.07M |
| March 31, 2021 | 47.56M |
| December 31, 2020 | 40.62M |
| September 30, 2020 | -11.18M |
| June 30, 2020 | -53.43M |
| Date | Value |
|---|---|
| March 31, 2020 | -77.51M |
| December 31, 2019 | -18.86M |
| September 30, 2019 | 13.96M |
| June 30, 2019 | 19.48M |
| March 31, 2019 | 73.75M |
| December 31, 2018 | 29.85M |
| September 30, 2018 | 5.018M |
| June 30, 2018 | -5.388M |
| March 31, 2018 | -54.30M |
| December 31, 2017 | -32.11M |
| September 30, 2017 | -55.94M |
| June 30, 2017 | -59.37M |
| March 31, 2017 | -64.79M |
| December 31, 2016 | -110.89M |
| September 30, 2016 | -118.88M |
| June 30, 2016 | -163.52M |
| March 31, 2016 | -153.83M |
| December 31, 2015 | -93.24M |
| September 30, 2015 | -79.19M |
| June 30, 2015 | -54.46M |
| March 31, 2015 | -21.99M |
| December 31, 2014 | -22.51M |
| September 30, 2014 | 5.42M |
| June 30, 2014 | 10.87M |
| March 31, 2014 | 16.96M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amarin Corp. Plc | 15.55M |
| Jazz Pharmaceuticals Plc | 1.508B |
| Prothena Corp. Plc | -62.08M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Biogen, Inc. | 2.49B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 145.18M |
| Cash from Investing (Quarterly) | -2.411M |
| Cash from Financing (Quarterly) | 17.20M |
| Free Cash Flow Per Share (Quarterly) | 0.7899 |
| Free Cash Flow to Equity (Quarterly) | 146.13M |
| Free Cash Flow to Firm (Quarterly) | 130.11M |
| Free Cash Flow Yield | 2.76% |